Jing Si

472 total citations
18 papers, 345 citations indexed

About

Jing Si is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Jing Si has authored 18 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 5 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Jing Si's work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (5 papers) and Breast Implant and Reconstruction (4 papers). Jing Si is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (5 papers) and Breast Implant and Reconstruction (4 papers). Jing Si collaborates with scholars based in China, United States and Germany. Jing Si's co-authors include Rong Guo, Jiong Wu, Weiru Chi, Yayun Chi, Jiajian Chen, Jingyan Xue, Bingqiu Xiu, Zhi‐Ming Shao, Qi Zhang and Lei Liu and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Jing Si

17 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Si China 10 204 168 80 46 38 18 345
Matt Church United Kingdom 4 135 0.7× 112 0.7× 73 0.9× 23 0.5× 19 0.5× 5 350
Martin Jones Canada 9 106 0.5× 190 1.1× 80 1.0× 36 0.8× 16 0.4× 25 356
Joanna Sobocińska Poland 9 166 0.8× 206 1.2× 47 0.6× 18 0.4× 20 0.5× 13 331
Helen M. Moore United States 4 147 0.7× 158 0.9× 57 0.7× 29 0.6× 24 0.6× 5 427
Laura Paladini Italy 5 216 1.1× 274 1.6× 71 0.9× 19 0.4× 17 0.4× 5 384
Musalula Sinkala Zambia 10 122 0.6× 188 1.1× 107 1.3× 19 0.4× 13 0.3× 29 380
Carina Strand Sweden 12 176 0.9× 178 1.1× 128 1.6× 24 0.5× 13 0.3× 14 407
Zi Liu China 12 70 0.3× 87 0.5× 99 1.2× 81 1.8× 86 2.3× 24 310
Takeshi Nagamatsu Japan 12 101 0.5× 135 0.8× 74 0.9× 28 0.6× 46 1.2× 31 323
Erica K. Barnell United States 10 82 0.4× 107 0.6× 108 1.4× 15 0.3× 31 0.8× 25 296

Countries citing papers authored by Jing Si

Since Specialization
Citations

This map shows the geographic impact of Jing Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Si more than expected).

Fields of papers citing papers by Jing Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Si. The network helps show where Jing Si may publish in the future.

Co-authorship network of co-authors of Jing Si

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Si. A scholar is included among the top collaborators of Jing Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Si. Jing Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Xiang, Qian, Zhiyan Liu, Qiufen Xie, et al.. (2025). Pharmacokinetics, pharmacodynamics and safety profile of SKB336, a selective inhibitor of coagulation factor XI/XIa in healthy subjects. British Journal of Clinical Pharmacology. 91(10). 2817–2826. 1 indexed citations
3.
4.
Si, Jing, Rong Guo, Bingqiu Xiu, et al.. (2022). Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. Frontiers in Oncology. 12. 927358–927358. 8 indexed citations
5.
Si, Jing, Rong Guo, Huan Pan, et al.. (2022). Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy. Frontiers in Oncology. 12. 869864–869864. 3 indexed citations
6.
7.
Si, Jing, Rong Guo, Huan Pan, et al.. (2020). Multiple Microinvasion Foci in Ductal Carcinoma In Situ Is Associated With an Increased Risk of Recurrence and Worse Survival Outcome. Frontiers in Oncology. 10. 607502–607502. 17 indexed citations
8.
9.
Si, Jing, Rong Guo, Xiang Lu, et al.. (2020). Decision aids on breast conserving surgery for early stage breast cancer patients: a systematic review. BMC Medical Informatics and Decision Making. 20(1). 275–275. 21 indexed citations
10.
Si, Jing, Fan Jiang, Bo Wei, et al.. (2020). Caspofungin combined with TMP/SMZ as a first‐line therapy for moderate‐to‐severe PCP in patients with human immunodeficiency virus infection. HIV Medicine. 22(4). 307–313. 17 indexed citations
11.
Si, Jing, Naisi Huang, Bingqiu Xiu, et al.. (2019). Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Biology and Medicine. 16(2). 312–312. 11 indexed citations
12.
Si, Jing, Rong Guo, Naisi Huang, et al.. (2019). Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Medicine. 8(18). 7586–7593. 2 indexed citations
13.
Xiu, Bingqiu, Yayun Chi, Lei Liu, et al.. (2019). LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Molecular Cancer. 18(1). 187–187. 169 indexed citations
14.
Guo, Rong, Jing Si, Yonghui Su, et al.. (2019). Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999−2017. Chinese Journal of Cancer Research. 31(4). 653–662. 27 indexed citations
15.
Si, Jing & Rong Guo. (2019). Abstract 1112: CCDC102B promotes metastatic cascade in breast cancer by activating NF-κB via down-regulating RACK1. Cancer Research. 79(13_Supplement). 1112–1112. 1 indexed citations
16.
17.
Si, Jing, J Chen, Benlong Yang, et al.. (2016). Current status of breast reconstruction in China: an experience of 951 breast reconstructions from a single institute. Gland Surgery. 5(3). 278–286. 22 indexed citations
18.
Ying, Shibo, Thomas Dünnebier, Jing Si, & Ute Hamann. (2013). Estrogen Receptor Alpha and Nuclear Factor Y Coordinately Regulate the Transcription of the SUMO-Conjugating UBC9 Gene in MCF-7 Breast Cancer Cells. PLoS ONE. 8(9). e75695–e75695. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matt Church Breakdown of academic impact, for papers by Martin Jones Breakdown of academic impact, for papers by Joanna Sobocińska Breakdown of academic impact, for papers by Helen M. Moore Breakdown of academic impact, for papers by Laura Paladini Breakdown of academic impact, for papers by Musalula Sinkala Breakdown of academic impact, for papers by Carina Strand Breakdown of academic impact, for papers by Zi Liu Breakdown of academic impact, for papers by Takeshi Nagamatsu Breakdown of academic impact, for papers by Erica K. Barnell
Rankless by CCL
2026